JPRN-jRCTs031180242已完成未知
A phase 2 trial to assess the safety of oral long-term NMN administration in healthy people - Safety evaluation of long-term NM
Itoh Hiroshi0 个研究点目标入组 30 人开始时间: 2019年3月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 <= 60age old（—）
- 性别
- Male
入选标准
- •healthy men
排除标准
- •Person who has diseases with medical diagnosis
研究者
相似试验
进行中（未招募）
1 期
A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular LymphomaMedDRA version: 14.1Level: LLTClassification code 10029478Term: Nodular lymphomaSystem Organ Class: 100000004864Follicular LymphomaEUCTR2013-002302-32-ITMillennium Pharmaceuticals, Inc.58
进行中（未招募）
1 期
A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular LymphomaFollicular LymphomaMedDRA version: 17.0 Level: LLT Classification code 10029478 Term: Nodular lymphoma System Organ Class: 100000004864EUCTR2013-002302-32-GBMillennium Pharmaceuticals, Inc.29
进行中（未招募）
1 期
A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular LymphomaFollicular LymphomaMedDRA version: 19.0Level: LLTClassification code 10029478Term: Nodular lymphomaSystem Organ Class: 100000004864EUCTR2013-002302-32-ESMillennium Pharmaceuticals, Inc.58
进行中（未招募）
1 期
A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular LymphomaFollicular LymphomaEUCTR2013-002302-32-BEMillennium Pharmaceuticals, Inc.58
进行中（未招募）
1 期
Study to determine whether adding MLN9708 to the combination of cyclophosphamide and dexamethasone improves the response to therapy in patients who have been newly diagnosed with multiple myeloma and have not received previous anti-myeloma treatmentewly diagnosed multiple myelomaMedDRA version: 14.1Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2013-003113-17-GRMillennium Pharmaceuticals, Inc.70